Delay in diagnosis of proton pump inhibitor induced hypomagnesaemia: A case series

Janett, 2016, Hypomagnesemia following prolonged use of proton-pump inhibitors, J Pediatr Gastroenterol Nutr, 62, e39, 10.1097/MPG.0000000000001087 Epstein, 2006, Proton-pump inhibitors and hypomagnesemic hypoparathyroidism, N Engl J Med, 355, 1834, 10.1056/NEJMc066308 Park, 2014, The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis, PLoS One [Electr Resour], 9 Cundy, 2008, Severe hypomagnesaemia in long-term users of proton-pump inhibitors, Clin Endocrinol (Oxf), 69, 338, 10.1111/j.1365-2265.2008.03194.x Shabajee, 2008, Omeprazole and refractory hypomagnesaemia, Bmj, 337, 10.1136/bmj.39505.738981.BE Zipursky, 2014, Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study, PLoS Med Public Lib Sci, 11 Hess, 2017, Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study, Pharmacogenetics Genom, 27, 83, 10.1097/FPC.0000000000000259 Toh, 2015, Hypomagnesaemia associated with long-term use of proton pump inhibitors, Gastroenterol Rep, 3, 243, 10.1093/gastro/gou054